The Motley Fool

FTSE 100 shares: 3 cheap UK shares I’d buy now to capitalise on the stock market recovery

Image source: Getty Images

The performance of many FTSE 100 shares over the last year has been hugely disappointing. A number of UK shares are trading at price levels significantly down on a one-year basis, as a struggling world economy has weighed on their prospects.

While further falls can’t be ruled out in the short term, they could offer long-term turnaround potential. A sustained stock market recovery has always been recorded after bear markets in the past. Therefore, with the following stocks currently offering wide margins of safety, now could be the right time to buy them in a diverse portfolio of UK stocks.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

A low valuation relative to other FTSE 100 shares

Lloyds Banking Group could offer a wide margin of safety compared to other FTSE 100 shares at the present time. The bank is experiencing very tough operating conditions caused by a weak economic performance and low interest rates. This could cause its financial performance to suffer in the first part of 2021. It also faces political uncertainty caused by Brexit.

However, this outlook may be priced in by investors. The bank’s shares have fallen by 45% in the past year. It now trades on a forward price-to-earnings (P/E) ratio of 10, which suggests there’s scope for a share price recovery. With the UK economy’s prospects likely to improve significantly between now and the end of the year, the outlook for Lloyds may change materially over the coming months and years.

A dividend opportunity relative to UK shares

GSK could also be an attractive investment versus other FTSE 100 shares. The company currently has a P/E ratio of under 12 as investors have seemingly cooled on its plans to split into two businesses.

This change could mean instability in the short run. However, it may also provide additional growth opportunities and efficiencies worth the cost of separation. With GSK currently having a dividend yield in excess of 5%, it also has a worthwhile passive income return. With interest rates likely to remain low for many months, if not years, it may become increasingly popular among a wider pool of investors.

A recovery opportunity following a tough period

Some FTSE 100 shares such as BT have been on a downward trend for many years. The telecoms giant now has a P/E ratio of 7.5 after its 30% stock price decline since January 2020.

Although the company’s financial prospects may be downbeat in the short run, its operational progress has been encouraging. For example, it’s becoming more efficient and is investing in areas such as 5G and faster broadband speeds.

This may provide the company with a competitive advantage that enables it to post rising profitability and a return to dividend payouts over the coming years. This may ignite investor interest in the stock and lead to a rise in its valuation.

A Top Share with Enormous Growth Potential

Savvy investors like you won’t want to miss out on this timely opportunity…

Here’s your chance to discover exactly what has got our Motley Fool UK analyst all fired up about this ‘pure-play’ online business (yes, despite the pandemic!).

Not only does this company enjoy a dominant market-leading position…

But its capital-light, highly scalable business model has previously helped it deliver consistently high sales, astounding near-70% margins, and rising shareholder returns … in fact, in 2019 it returned a whopping £150m+ to shareholders in dividends and buybacks!

And here’s the really exciting part…

While COVID-19 may have thrown the company a curveball, management have acted swiftly to ensure this business is as well placed as it can be to ride out the current period of uncertainty… in fact, our analyst believes it should come roaring back to life, just as soon as normal economic activity resumes.

That’s why we think now could be the perfect time for you to start building your own stake in this exceptional business – especially given the shares look to be trading on a fairly undemanding valuation for the year to March 2021.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Growth Share… free of charge!

Peter Stephens owns shares of GlaxoSmithKline and Lloyds Banking Group. The Motley Fool UK has recommended GlaxoSmithKline and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.